<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This prospective, observational study was carried out in a teaching hospital in Calcutta, India </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the study was to evaluate the prevalence of anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (APS) among women with <z:e sem="disease" ids="C0000809" disease_type="Disease or Syndrome" abbrv="">recurrent miscarriages</z:e>/<z:e sem="disease" ids="C0878751" disease_type="Disease or Syndrome" abbrv="">late pregnancy</z:e> loss when no other apparent causes were identified, in the study population </plain></SENT>
<SENT sid="2" pm="."><plain>The women were put through a variety of investigations to determine the cause of <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage</z:e>/pregnancy loss </plain></SENT>
<SENT sid="3" pm="."><plain>Only those women who had a <z:mpath ids='MPATH_458'>normal</z:mpath> result for <z:hpo ids='HP_0000001'>all</z:hpo> the investigation went for the anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibodies (APLA) test </plain></SENT>
<SENT sid="4" pm="."><plain>The expelled products of conception/placenta were also sent for histopathological confirmation </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 445 women were studied over a 4-year period </plain></SENT>
<SENT sid="6" pm="."><plain>A total of 155 women were offered a screening for APLA antibodies </plain></SENT>
<SENT sid="7" pm="."><plain>Out of them, 43 women (27.7%) tested positive for APLA </plain></SENT>
<SENT sid="8" pm="."><plain>Histopathological evidence was present in <z:hpo ids='HP_0000001'>all</z:hpo> the specimens </plain></SENT>
<SENT sid="9" pm="."><plain>Interestingly, one woman had histopathological evidence of <z:mp ids='MP_0005048'>thrombosis</z:mp>, but her blood tests for the antibody were negative </plain></SENT>
</text></document>